Michael David Smith - Net Worth and Insider Trading
Michael David Smith Net Worth
The estimated net worth of Michael David Smith is at least $0 dollars as of 2024-05-10. Michael David Smith is the Senior VP, Development of KalVista Pharmaceuticals Inc and owns about 0 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $0. Details can be seen in Michael David Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael David Smith has not made any transactions after 2021-06-01 and currently still holds the listed stock(s).
Transaction Summary of Michael David Smith
Michael David Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael David Smith owns 1 companies in total, including KalVista Pharmaceuticals Inc (KALV) .
Click here to see the complete history of Michael David Smith’s form 4 insider trades.
Insider Ownership Summary of Michael David Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2021-06-01 | Senior VP & Development |
Michael David Smith Latest Holdings Summary
Michael David Smith currently owns a total of 1 stock. Michael David Smith owns 0 shares of KalVista Pharmaceuticals Inc (KALV) as of June 1, 2021, with a value of $0.
Latest Holdings of Michael David Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2021-06-01 | 0 | 12.07 | 0 |
Holding Weightings of Michael David Smith
Michael David Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael David Smith has made a total of 2 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 7,500 shares on June 1, 2021, which brought Michael David Smith around $201,225.
Insider Trading History of Michael David Smith
- 1
Michael David Smith Trading Performance
Michael David Smith Ownership Network
Michael David Smith Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Michael David Smith is the Senior VP & Development of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include director & President and CEO Thomas Andrew Crockett , Chief Medical Officer Paul K. Audhya , and CFO and Secretary Benjamin L Palleiko .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Michael David Smith made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 167,039 shares made by Thomas Andrew Crockett , and a net sale of 110,937 shares made by Edward P. Feener .
In summary, during the past 3 months, insiders sold 269,594 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 269,594 shares. During the past 18 months, 505,299 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 745,718 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Michael David Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Michael David Smith. You might contact Michael David Smith via mailing address: C/o Kalvista Pharmaceuticals, Inc., 55 Cambridge Parkway, Suite 901e, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
